- Home
- BCOW vs TARA Comparison
BCOW vs TARA Comparison
Compare BCOW & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCOW
- TARA
- Stock Information
- Founded
- BCOW 1895
- TARA N/A
- Country
- BCOW United States
- TARA United States
- Employees
- BCOW N/A
- TARA N/A
- Industry
- BCOW Finance: Consumer Services
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BCOW Finance
- TARA Health Care
- Exchange
- BCOW Nasdaq
- TARA Nasdaq
- Market Cap
- BCOW 54.9M
- TARA 52.4M
- IPO Year
- BCOW 2019
- TARA N/A
- Fundamental
- Price
- BCOW $9.98
- TARA $2.39
- Analyst Decision
- BCOW
- TARA Strong Buy
- Analyst Count
- BCOW 0
- TARA 2
- Target Price
- BCOW N/A
- TARA $24.00
- AVG Volume (30 Days)
- BCOW 3.5K
- TARA 156.1K
- Earning Date
- BCOW 11-08-2024
- TARA 11-12-2024
- Dividend Yield
- BCOW N/A
- TARA N/A
- EPS Growth
- BCOW N/A
- TARA N/A
- EPS
- BCOW N/A
- TARA N/A
- Revenue
- BCOW $11,828,000.00
- TARA N/A
- Revenue This Year
- BCOW N/A
- TARA N/A
- Revenue Next Year
- BCOW N/A
- TARA N/A
- P/E Ratio
- BCOW N/A
- TARA N/A
- Revenue Growth
- BCOW N/A
- TARA N/A
- 52 Week Low
- BCOW $6.05
- TARA $1.13
- 52 Week High
- BCOW $10.45
- TARA $5.24
- Technical
- Relative Strength Index (RSI)
- BCOW 52.77
- TARA 53.71
- Support Level
- BCOW $9.90
- TARA $2.21
- Resistance Level
- BCOW $10.00
- TARA $2.74
- Average True Range (ATR)
- BCOW 0.07
- TARA 0.16
- MACD
- BCOW -0.02
- TARA -0.05
- Stochastic Oscillator
- BCOW 27.59
- TARA 31.58
About BCOW 1895 Bancorp of Wisconsin Inc. (MD)
1895 Bancorp of Wisconsin Inc acts as the mutual holding company reorganization of PyraMax Bank, FSB, to become the savings and loan holding company of PyraMax Bank, FSB. Its business consists predominantly of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one-to-four family residential real estate loans, commercial real estate loans, commercial loans, and consumer loans.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).